Citation
- Authors: Kim EH. et al.
- Year: 2020
- Journal: Cancers 12 1203
- Applications: in vivo / miRNA / in vivo-jetPEI
Method
Therapy was started when the tumor volume reached ~200 mm3 (Mice = Lymphoma Xenograpft Subcutaneous model)
Abstract
Backgrounds: Radioimmunotherapy (RIT) serves as a targeted therapy for non-Hodgkin lymphomas (NHL). Although HIF(Hypoxia-inducible factors)-1